Skip to main content

Table 1 Anthropometric and serum metabolic parameters in all groups

From: Effect of irisin on metabolic and platelet functions in type 2 diabetic rats: role of soluble receptor of advanced glycation end products (sRAGE)

 

Group I

Group IIa

Group IIb

Initial BW (g)

200.82 ± 10.51

200.36 ± 9.53

200.64 ± 10.60

Final BW (g)

200.27 ± 15.58

307.54 ± 33.54a*

285.45 ± 27.06a*

FBG (mg/dl)

88.91 ± 6.59

249.27 ± 23.82a*

148.36 ± 14.68a*b*

Insulin (mIU/ml)

24.98 ± 3.03

37.37 ± 7.86a*

31.08 ± 7.52a*b*

HOMA-IR

5.44 ± 0.60

22.81 ± 4.31a#

11.28 ± 2.83a#b#

TC (mg/dl)

68.73 ± 13.23

109.00 ± 17.58a#

85.27 ± 9.80a*b*

TG (mg/dl)

44.73 ± 7.17

195.64 ± 49.67a#

122.09 ± 37.57a#b*

HDL (mg/dl)

29.73 ± 7.15

22.36 ± 4.98a*

30.00 ± 8.08b*

LDL (mg/dl)

30.07 ± 9.04

47.53 ± 12.36a*

30.84 ± 7.83b*

VLDL (mg/dl)

8.95 ± 1.43

39.13 ± 9.93a#

24.42 ± 7.51a#b*

sRAGES (ng/ml)

6.07 ± 0.51

5.40 ± 0.77a*

6.02 ± 0.53b*

  1. All data are expressed as mean ± SD
  2. *p < 0.05
  3. #p < 0.001
  4. aSignificant compared to group I
  5. bSignificant compared to group IIa